• L04AG03 3 drugs
• L04AG04 3 drugs
• L04AG05 2 drugs
• L04AG06 1 drugs
• L04AG08 1 drugs
• L04AG10 1 drugs
• L04AG11 1 drugs
• L04AG12 1 drugs
• L04AG14 1 drugs

Drugs with code L04AG

• BENLYSTA 120 MG POWDER FOR CONCENTRATE FOR INFUSION SOLUTION

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  belimumab	120 mg

  ATC code: L04A, L04AG, L04AG04

  Manufacturer: Glaxosmithkline (Ireland) Limited

• BENLYSTA 200 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  belimumab	200 mg

  ATC code: L04A, L04AG, L04AG04

  Manufacturer: Glaxosmithkline (Ireland) Limited

• BENLYSTA 400 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  belimumab	400 mg

  ATC code: L04A, L04AG, L04AG04

  Manufacturer: Glaxosmithkline (Ireland) Limited

• BRIUMVI 150 MG CONCENTRATE FOR SOLUTION FOR INFUSION

  Form: solution for infusion, concentrate

  Active substance	Dosage
  ublituximab	150 mg

  ATC code: L04A, L04AG, L04AG14

  Manufacturer: Neuraxpharm Pharmaceuticals S.L.

• ENTYVIO 108 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  vedolizumab	108 mg

  ATC code: L04A, L04AG, L04AG05

  Manufacturer: Takeda Pharma A/S

• ENTYVIO 300 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  vedolizumab	300 mg

  ATC code: L04A, L04AG, L04AG05

  Manufacturer: Takeda Pharma A/S

• KESIMPTA 20 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  ofatumumab	20 mg

  ATC code: L04A, L04AG, L04AG12

  Manufacturer: Novartis Europharm Limited

• LEMTRADA 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION

  Form: solution for infusion, concentrate

  Active substance	Dosage
  alemtuzumab	10,0 mg

  ATC code: L04A, L04AG, L04AG06

  Manufacturer: Sanofi Belgium

• OCREVUS 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION

  Form: solution for infusion, concentrate

  Active substance	Dosage
  ocrelizumab	30 mg

  ATC code: L04A, L04AG, L04AG08

  Manufacturer: Roche Registration Gmbh

• SAPHNELO 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION

  Form: solution for infusion, concentrate

  Active substance	Dosage
  anifrolumab	300 mg

  ATC code: L04A, L04AG, L04AG11

  Manufacturer: Astrazeneca Ab

• TYRUKO 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION

  Form: solution for infusion, concentrate

  Active substance	Dosage
  natalizumab	300 mg

  ATC code: L04A, L04AG, L04AG03

  Manufacturer: Sandoz Gmbh

• TYSABRI 150 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  natalizumab	150 mg/ml

  ATC code: L04A, L04AG, L04AG03

  Manufacturer: Biogen Netherlands B.V.

• TYSABRI 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION

  Form: solution for infusion, concentrate

  Active substance	Dosage
  natalizumab	20 mg

  ATC code: L04A, L04AG, L04AG03

  Manufacturer: Biogen Netherlands B.V.

• UPLIZNA 100 MG CONCENTRATE FOR SOLUTION FOR INFUSION

  Form: solution for infusion, concentrate

  Active substance	Dosage
  inebilizumab	10 mg/ml

  ATC code: L04A, L04AG, L04AG10

  Manufacturer: Amgen Europe B.V.